EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Extension of cytokines’ role in Behcet’s disease associated peripheral neuropathy

Amira Elsonbaty, Helal Hetta, Ahmed Nasreldein, Manal Hassanien

Clinical Rheumatology · 2026-08 · 45 (8) · 5005-5012

DOI: 10.1007/s10067-026-08258-w ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Clinical Rheumatology, online erschienen am 03.07.2026. Verfasst von Amira Elsonbaty und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, Rehabilitation and Physical Medicine, Faculty of Medicine, Assiut University, Assiut, 71112, Egypt. dramiramelsonbaty@gma…. Hauptthemen laut MEDLINE: Behcet Syndrome, Chemokine CCL21, Peripheral Nervous System Diseases. Die Arbeit nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND/OBJECTIVE: Behçet's disease (BD) is a chronic multisystem inflammatory disorder with diverse neurological manifestations. While central nervous system involvement is well recognized, peripheral neuropathy remains an underdiagnosed and poorly understood complication. Chemokines, particularly C-C motif chemokine ligand 21 (CCL21), play a critical role in immune-mediated neuroinflammation and have been implicated in several autoimmune diseases. This study aimed to investigate the association between selected CCL21 gene polymorphisms and BD-associated peripheral neuropathy, and to assess their relationship with disease activity. METHODS: This cross-sectional observational study included 42 adult patients with BD and 20 age- and sex-matched healthy controls. All patients underwent comprehensive clinical and neurological evaluation, assessment of disease activity, and nerve conduction studies. Genotyping of CCL21 single nucleotide polymorphisms rs951005, rs2492358, and rs2812378 were performed for patients and controls. RESULTS: Electrophysiological evidence of peripheral neuropathy was detected in all evaluated Behçet's disease patients, despite only 50% reporting clinical neuropathic symptoms. Polyneuropathy was the predominant pattern, with sensory and mixed nerves more frequently affected than purely motor nerves, and greater involvement of upper limb nerves. A significant difference in the distribution of the CCL21 rs2492358 polymorphism was observed between patients and controls (p = 0.001). Additionally, the rs951005 polymorphism was significantly associated with higher disease activity scores (p = 0.009). CONCLUSION: Peripheral neuropathy is a frequent and often subclinical manifestation of BD. CCL21 gene polymorphisms appear to contribute to both peripheral neuropathy association and disease activity, highlighting CCL21 as a potential biomarker linking systemic inflammation to peripheral nerve involvement. Key Points • Chemokine dysregulation previously found to play a central role in the development of neuroinflammation. • This cross-sectional study identifies specific chemokines' gene of CCL21 linked to peripheral neuropathy in Behcet's disease. • Results may guide future therapeutic strategies targeting chemokine modulation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Behcet SyndromeChemokine CCL21Peripheral Nervous System DiseasesHumansFemaleMaleAdultCross-Sectional StudiesPolymorphism, Single NucleotideMiddle AgedNerve Conduction StudiesCase-Control StudiesGenetic Predisposition to DiseaseGenotype

Stichwörter der Autor:innen

Behçet’s diseaseCCL21ChemokinesDisease activityNeuroinflammationPeripheral neuropathySingle nucleotide polymorphism

Substanzen

Chemokine CCL21CCL21 protein, human

Autor:innen und Institutionen

  • Department of Rheumatology, Rehabilitation and Physical Medicine, Faculty of Medicine, Assiut University, Assiut, 71112, Egypt. dramiramelsonbaty@gmail.com.
  • Medical Microbiology and Immunology Department, Faculty of Medicine, Assiut University, Assiut, Egypt.
  • Department of Neurology, Faculty of Medicine, Assiut University, Assiut, Egypt.
  • Department of Rheumatology, Rehabilitation and Physical Medicine, Faculty of Medicine, Assiut University, Assiut, 71112, Egypt.

Zitieren

APA

Elsonbaty, A., Hetta, H., Nasreldein, A., & Hassanien, M. (2026). Extension of cytokines’ role in Behcet’s disease associated peripheral neuropathy. Clinical Rheumatology, 45(8), 5005-5012. https://doi.org/10.1007/s10067-026-08258-w

Vancouver

Elsonbaty A, Hetta H, Nasreldein A, Hassanien M. Extension of cytokines’ role in Behcet’s disease associated peripheral neuropathy. Clinical Rheumatology. 2026;45(8):5005-5012. doi:10.1007/s10067-026-08258-w

BibTeX
@article{Elsonbaty2026,
  author = {Elsonbaty, Amira and Hetta, Helal and Nasreldein, Ahmed and Hassanien, Manal},
  title = {Extension of cytokines’ role in Behcet’s disease associated peripheral neuropathy},
  journal = {Clinical Rheumatology},
  year = {2026},
  volume = {45},
  number = {8},
  pages = {5005--5012},
  doi = {10.1007/s10067-026-08258-w}
}
Kostenlos starten →